DRD — DrdGOLD Share Price

As of Today at 19:19 UTC, shares in DrdGOLD are trading at $31.24. This share price information is delayed by 15 minutes.

Shares in DrdGOLD last closed at $31.24 and the price had moved by +257.44% over the past 365 days. In terms of relative price strength the DrdGOLD share price has outperformed the S&P500 Index by +210.18% over the past year.

The overall consensus recommendation for DrdGOLD is Buy. You can view the full broker recommendation list by unlocking its StockReport.

The DrdGOLD dividend yield is 1.34% based on the trailing twelve month period.

Last year, DrdGOLD paid a total dividend of ZAR7.00, and it currently has a trailing dividend yield of 1.34%. We do not have any data on when DrdGOLD is to next pay dividends.

We do not have data on when DrdGOLD is to next pay dividends.  The historic dividend yield on DrdGOLD shares is currently 1.34%.

To buy shares in DrdGOLD you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

As of the previous close price of $31.24, shares in DrdGOLD had a market capitalisation of $2.68bn.

Here are the trading details for DrdGOLD: 

• Country of listing: United States
• Exchange: NYQ
• Ticker Symbol: DRD

Based on an overall assessment of its quality, value and momentum DrdGOLD is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

The analyst consensus target price for shares in DrdGOLD is $36.17.  That is 15.78% above the last closing price of $31.24.

Analysts covering DrdGOLD currently have a consensus Earnings Per Share (EPS) forecast of ZAR24.26 for the next financial year.

An important predictor of whether a stock price will go up is its track record of momentum.  Price trends tend to persist, so it's worth looking at them when it comes to a share like DrdGOLD. Over the past six months, its share price has outperformed the S&P500 Index by +98.85%.

As of the last closing price of $31.24, shares in DrdGOLD were trading +60.04% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

The DrdGOLD PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $31.24. 

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

DrdGOLD's management team is headed by: 

• Timothy Cumming - NEC
• Daniel Pretorius - CEO
• A. Davel - CFO
• Thulo Mogotsi-Moletsane - CEX
• Shalin Naidoo - CTO
• Mark Burrell - OTH
• Henry Gouws - OTH
• Henriette Hooijer - OTH
• Kevin Kruger - OTH
• Wilhelm Schoeman - OTH
• Elise Beukes - SEC
• Edmund Jeneker - LED
• Charmel Flemming - NID
• Johan Holtzhausen - NID
• K. Prudence Lebina - NID
• Jean Nel - NID
• Toko Victoria Nomalanga Mnyango - NID